Skip to content
Parakho

Syngene International Ltd

NSE SYNGENEBSE 539268syngeneintl.com

Q1 FY27, unaudited

Revenue
₹736.00 Cr
Profit after tax
₹-9.00 Cr

As filed with the exchange, consolidated basis.

Board meeting

Syngene International Ltd has given BSE notice of a board meeting on 27 Oct 2026 to consider Q2 FY27 results. Notice · Results calendar

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations736.00−15.84%3,738.70
Other income25.30+42.94%70.70
Total income761.30−14.67%3,809.40
Employee benefit expense259.10−0.99%1,104.90
Finance costs9.60−17.24%48.80
Depreciation & amortisation112.20+0.90%452.90
Total expenses767.00−3.02%3,321.90
Profit before tax-19.20−118.95%410.90
Tax expense-10.20−169.86%94.20
Profit after tax-9.00−110.38%316.70
Total comprehensive income26.30−75.67%120.70
Earnings per share
Earnings per share, basic₹-0.22₹7.87
Earnings per share, diluted₹-0.22₹7.87

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Syngene International Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 66 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Healthcare Research, Analytics & Technology

Classification as published by BSE.

Companies also in Healthcare Research, Analytics & Technology, in alphabetical order

All 11 companies in Healthcare Research, Analytics & Technology

Page generated from filings held to 08 Oct 2026.